Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1907 1
1948 1
1951 2
1953 4
1954 3
1956 5
1957 4
1958 6
1959 5
1960 3
1961 1
1962 2
1963 1
1964 5
1965 2
1966 5
1967 3
1968 1
1969 3
1970 2
1971 2
1972 7
1973 4
1974 4
1975 2
1976 3
1977 6
1978 5
1979 14
1980 10
1981 4
1982 8
1983 17
1984 13
1985 14
1986 22
1987 15
1988 18
1989 15
1990 15
1991 17
1992 11
1993 14
1994 14
1995 15
1996 17
1997 13
1998 20
1999 15
2000 25
2001 16
2002 15
2003 7
2004 15
2005 22
2006 21
2007 18
2008 21
2009 14
2010 20
2011 20
2012 26
2013 18
2014 23
2015 21
2016 23
2017 18
2018 25
2019 44
2020 28
2021 31
2022 30
2023 25
2024 31
2025 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

907 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.
Minard-Colin V, Aupérin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, Delgado RF, Alexander S, Uyttebroeck A, Bollard CM, Zsiros J, Csoka M, Kazanowska B, Chiang AK, Miles RR, Wotherspoon A, Adamson PC, Vassal G, Patte C, Gross TG; European Intergroup for Childhood Non-Hodgkin Lymphoma; Children’s Oncology Group. Minard-Colin V, et al. Among authors: miles rr. N Engl J Med. 2020 Jun 4;382(23):2207-2219. doi: 10.1056/NEJMoa1915315. N Engl J Med. 2020. PMID: 32492302 Free PMC article. Clinical Trial.
Reply.
Yi SY, Narayan AK, Miles RC, Martin Rother MD, Robbins JB, Flores EJ, Ross AB. Yi SY, et al. Among authors: miles rc. J Am Coll Radiol. 2024 Aug;21(8):1157-1158. doi: 10.1016/j.jacr.2024.01.019. Epub 2024 Feb 1. J Am Coll Radiol. 2024. PMID: 38295919 No abstract available.
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis.
Yoshimi A, Lin KT, Wiseman DH, Rahman MA, Pastore A, Wang B, Lee SC, Micol JB, Zhang XJ, de Botton S, Penard-Lacronique V, Stein EM, Cho H, Miles RE, Inoue D, Albrecht TR, Somervaille TCP, Batta K, Amaral F, Simeoni F, Wilks DP, Cargo C, Intlekofer AM, Levine RL, Dvinge H, Bradley RK, Wagner EJ, Krainer AR, Abdel-Wahab O. Yoshimi A, et al. Among authors: miles re. Nature. 2019 Oct;574(7777):273-277. doi: 10.1038/s41586-019-1618-0. Epub 2019 Oct 2. Nature. 2019. PMID: 31578525 Free PMC article.
Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.
Hayashi RJ, Winter SS, Dunsmore KP, Devidas M, Chen Z, Wood BL, Hermiston ML, Teachey DT, Perkins SL, Miles RR, Raetz EA, Loh ML, Winick NJ, Carroll WL, Hunger SP, Lim MS, Gross TG, Bollard CM. Hayashi RJ, et al. Among authors: miles rr. J Clin Oncol. 2020 Sep 10;38(26):3062-3070. doi: 10.1200/JCO.20.00531. Epub 2020 Jun 17. J Clin Oncol. 2020. PMID: 32552472 Free PMC article. Clinical Trial.
Catabolism in mollicutes.
Miles RJ. Miles RJ. J Gen Microbiol. 1992 Sep;138(9):1773-83. doi: 10.1099/00221287-138-9-1773. J Gen Microbiol. 1992. PMID: 1402786 Review.
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.
Hayashi RJ, Hermiston ML, Wood BL, Teachey DT, Devidas M, Chen Z, Annett RD, Asselin BL, August K, Cho S, Dunsmore KP, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju A, Lam A, Messinger YH, Miles RR, Okada M, Patel S, Schafer ES, Schechter T, Shimano KA, Singh N, Steele A, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay PA, Loh ML, Hunger SP, Raetz EA, Bollard CM, Allen CE. Hayashi RJ, et al. Among authors: miles rr. Blood. 2024 May 16;143(20):2053-2058. doi: 10.1182/blood.2023021184. Blood. 2024. PMID: 38457359 Free PMC article. Clinical Trial.
Reply to R. Lakhotia et al.
Burke GAA, Minard-Colin V, Aupérin A, Alexander S, Pillon M, Delgado R, Zsíros J, Uyttebroeck A, Dartigues P, Miles RR, Kazanowska B, Chiang AK, Haouy S, Bollard CM, Csoka M, Wheatley K, Barkauskas DA, Adamson PC, Vassal G, Patte C, Gross TG. Burke GAA, et al. Among authors: miles rr. J Clin Oncol. 2022 Jun 20;40(18):2064-2066. doi: 10.1200/JCO.21.02912. Epub 2022 Apr 4. J Clin Oncol. 2022. PMID: 35377710 No abstract available.
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1.
Guest EM, Kairalla JA, Devidas M, Hibbitts E, Carroll AJ, Heerema NA, Kubaney HR, August MA, Ramesh S, Yoo B, Farooqi MS, Pauly MG, Wechsler DS, Miles RR, Reid JM, Kihei CD, Gore L, Raetz EA, Hunger SP, Loh ML, Brown PA. Guest EM, et al. Among authors: miles rr. Haematologica. 2024 Dec 1;109(12):3918-3927. doi: 10.3324/haematol.2024.285158. Haematologica. 2024. PMID: 38867582 Free PMC article. Clinical Trial.
Lymphoma diagnostics: getting more from less.
Galardy PJ, Bedekovics T, Macintyre E, Miles RR. Galardy PJ, et al. Among authors: miles rr. Br J Haematol. 2019 Jun;185(6):1136-1141. doi: 10.1111/bjh.15788. Epub 2019 Feb 19. Br J Haematol. 2019. PMID: 30784044 Review.
907 results